Exposure to exogenous DNA can modify the sensitivity of the Fas apoptotic pathway

被引:6
作者
Bittencourt, MD [1 ]
Saas, P [1 ]
Fresnay, S [1 ]
Yerly-Motta, V [1 ]
Ferrand, C [1 ]
Perruche, S [1 ]
Duperrier, A [1 ]
Hervé, P [1 ]
Tiberghien, P [1 ]
Chalmers, DE [1 ]
机构
[1] Univ Franche Comte, INSERM E0119 UPRES EA2284, Etab Francais Sang Bourgogne France Comt, F-25020 Besancon, France
关键词
Fas; Fas ligand; apoptosis; exogenous DNA; gene therapy;
D O I
10.1002/jgm.226
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background Gene-transfer techniques are commonly employed for both in vitro and in vivo studies. However, modifications of the target cell following the introduction of the gene of interest are not often examined. These modifications can alter the immunogenicity and/or the susceptibility of the target cell to apoptosis and may produce unwanted consequences in vivo. Methods Gene transfer into the murine fibroblastic Psi-CRIP packaging cell line was performed using calcium phosphate precipitation, cationic liposome-DNA complexes or a retroviral RNA-mediatcd method. After gene transfer, Fas expression, cytokine production, and sensitivity to Fas ligand (FasL)-mediated death were assessed. Results Following transfection of a FasL expression vector by calcium phosphate precipitation, an unexpected increase was observed in apoptotic cell death in previously Fas-resistant Psi-CRIP cells. This apoptosis was due to Fas upregulation and an increase of sensitivity to FasL-mediated death. Other plasmids coding non-cytotoxic factors also modulated this apoptotic pathway. The co-stimulatory molecule CD80 was also upregulated. Exposure to naked DNA alone elicited the same response. The effect was not dependent on the methylation status of exogenous DNA, but was found to be dependent on the target cell type and might be avoided by the use of an RNA-mediated retroviral system. Conclusions Plasmid transfection or simple exposure to naked DNA can increase sensitivity to apoptosis. The generation of FasL packaging cell lines is therefore limited by an increase in FasL/Fas-mediated apoptosis. These findings should be considered when using genetically modified transplantable cells in order to prevent elimination by host cytotoxic cells and in particular when cells are engineered using FasL. Copyright (C) 2001 John Wiley Sons, Ltd.
引用
收藏
页码:14 / 24
页数:11
相关论文
共 52 条
[1]   Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts [J].
Allison, J ;
Georgiou, HM ;
Strasser, A ;
Vaux, DL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (08) :3943-3947
[2]   Gene transfer of Fas ligand induces tumor regression in vivo [J].
Arai, H ;
Gordon, D ;
Nabel, EG ;
Nabel, GJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (25) :13862-13867
[3]  
Baum C, 1996, J Hematother, V5, P323, DOI 10.1089/scd.1.1996.5.323
[4]   FUNCTIONS FOR DNA METHYLATION VERTEBRATES [J].
BIRD, AP .
COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, 1993, 58 :281-285
[5]   Interactions between the immune system and gene therapy vectors: Bidirectional regulation of response and expression [J].
Bromberg, JS ;
Debruyne, LA ;
Qin, LH .
ADVANCES IN IMMUNOLOGY, VOL 69, 1998, 69 :353-409
[6]  
Budker V, 2000, J GENE MED, V2, P76, DOI 10.1002/(SICI)1521-2254(200003/04)2:2<76::AID-JGM97>3.0.CO
[7]  
2-4
[8]   Targeted antigen delivery to antigen-presenting cells including dendritic cells by engineered Fas-mediated apoptosis [J].
Chattergoon, MA ;
Kim, JJ ;
Yang, JS ;
Robinson, TM ;
Lee, DJ ;
Dentchev, T ;
Wilson, DM ;
Ayyavoo, V ;
Weiner, DB .
NATURE BIOTECHNOLOGY, 2000, 18 (09) :974-979
[9]   In vivo alloreactive potential of ex vivo expanded primary T lymphocytes [J].
Contassot, E ;
Murphy, W ;
Angonin, R ;
Pavy, JJ ;
Bittencourt, MC ;
Robinet, R ;
Reynolds, CW ;
Cahn, JY ;
Herve, P ;
Tiberghien, P .
TRANSPLANTATION, 1998, 65 (10) :1365-1370
[10]   HIGH-TITER PACKAGING CELLS PRODUCING RECOMBINANT RETROVIRUSES RESISTANT TO HUMAN SERUM [J].
COSSET, FL ;
TAKEUCHI, Y ;
BATTINI, JL ;
WEISS, RA ;
COLLINS, MKL .
JOURNAL OF VIROLOGY, 1995, 69 (12) :7430-7436